RNS Number: 2640V
Bupa Finance plc has today given notice to the holders of its £330 million callable subordinated perpetual guaranteed bonds issued in December 2004 (the “Bonds”) that it intends to redeem the Bonds in full on 16 September 2020, in accordance with Condition 5.3 (Redemption at the Issuer’s Option) of the terms and conditions of the Bonds (as set out in the Offering Circular dated 15 December 2004).
For further information, please contact:
Investors
Investor Relations: [email protected]
Media
Rupert Gowrley (Corporate Affairs): [email protected]
DISCLAIMER
This announcement is not intended to and does not constitute or form part of any offer to sell or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor or be considered a recommendation that any investor should subscribe for or purchase or invest in any securities.
The securities described in this announcement have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended, or under any relevant securities laws of any state of the United States of America and may not be offered, sold or delivered in the United States of America or to, or for the account of or benefit of, U.S. Persons, subject to certain limited exemptions.
About Bupa
Bupa's purpose is helping people live longer, healthier, happier lives and making a better world.
We are an international healthcare company serving over 31 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers.
We directly employ around 85,000 people, principally in the UK, Australia, Spain, Chile, Poland, New Zealand, Hong Kong SAR, Turkey, Brazil, Mexico, the US, Middle East and Ireland. We also have associate businesses in Saudi Arabia and India.
